Dr. Reddy's Laboratories Ltd. 8-2-337, Road No. 3, Banjara Hills, Hyderabad - 500 034, Telangana, India. CIN: L85195TG1984PLC004507 Tel : +91 40 4900 2900 Fax : +91 40 4900 2999 Email : mail@drreddys.com www.drreddys.com

Please find enclosed a Press Release on "Dr.

Reddy's Laboratories announces acquisition of ANDA portfolio"

This is for your information.

CC:- New York Stock Exchange Inc.(Stock Code :RDY)

Laboratories announces acquisition

Hyderabad, India and Princeton, NJ, USA. April 13, 2019 -

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as

"Dr. Reddy's") announced today that it has entered into a definitive agreement to acquire a portfolio of 42 approved,

non-marketed Abbreviated New Drug Applications (ANDAs) in the U.S.

The portfolio includes more than 30 generic injectable products.

These products will require to be technology transferred and could be launched within the next one to two years. The value of total

addressable market for these products in the U.S. is approximately $645 million for the calendar year ending in December 2018 according

Erez Israeli, Chief Operating Officer of Dr. Reddy's Laboratories,

commented, "The acquisition is in line with our stated strategy to significantly enhance our portfolio in our chosen growth

markets. This transaction will help augment our injectables product portfolio in the U.S. market and globally."

About Dr. Reddy's: Dr. Reddy's Laboratories

Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) is an integrated pharmaceutical company, committed to providing affordable and innovative

medicines for healthier lives. Through its three businesses - Pharmaceutical Services & Active Ingredients, Global Generics

and Proprietary Products - Dr. Reddy's offers a portfolio of products and services including APIs, custom pharmaceutical

services, generics, biosimilars and differentiated formulations. Our major therapeutic areas of focus are gastrointestinal, cardiovascular,

diabetology, oncology, pain management and dermatology. Dr. Reddy's operates in markets across the globe. Our major markets

include - USA, India, Russia & CIS countries, and Europe. For more information, log on to: www.drreddys.com

Disclaimer: This press release may include statements of

future expectations and other forward-looking statements that are based on the management's current views and assumptions

and involve known or unknown risks and uncertainties that could cause actual results, performance or events to differ materially

from those expressed or implied in such statements. In addition to statements which are forward-looking by reason of context, the

words "may", "will", "should", "expects", "plans", "intends", "anticipates",

"believes", "estimates", "predicts", "potential", or "continue" and similar expressions

identify forward-looking statements. Actual results, performance or events may differ materially from those in such statements

due to without limitation, (i) general economic conditions such as performance of financial markets, credit defaults , currency

exchange rates , interest rates , persistency levels and frequency / severity of insured loss events (ii) mortality and morbidity

levels and trends, (iii) changing levels of competition and general competitive factors, (iv) changes in laws and regulations and

in the policies of central banks and/or governments, (v) the impact of acquisitions or reorganization , including related integration

The company assumes no obligation to update any information contained